We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$299M
AUM Growth
-$7.34M
Cap. Flow
-$6.4M
Cap. Flow %
-2.14%
Top 10 Hldgs %
79.82%
Holding
71
New
4
Increased
2
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
AXLA
Axcella Health Inc. Common Stock
AXLA
+$1.9M
2
PAYO icon
Payoneer
PAYO
+$1.86M
3
PCOR icon
Procore
PCOR
+$940K
4
RKLB icon
Rocket Lab Corp
RKLB
+$417K
5
LZ icon
LegalZoom.com
LZ
+$397K

Top Sells

Rank Stock Value
1
GTM
ZoomInfo Technologies
GTM
+$8.07M
2
PLRX icon
Pliant Therapeutics
PLRX
+$1.35M
3
STRY
Starry Group Holdings, Inc.
STRY
+$993K
4
RVMD icon
Revolution Medicines
RVMD
+$869K
5
FLYW icon
Flywire
FLYW
+$394K

Sector Composition

Rank Sector Weight
1 Technology 66.46%
2 Consumer Discretionary 14.25%
3 Healthcare 12.61%
4 Communication Services 2.06%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
51
Pacific Biosciences
PACB
$460M
$192K 0.06%
23,484
– –
RPTX
52
DELISTED
Repare Therapeutics
RPTX
$181K 0.06%
12,276
– –
DCT
53
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$175K 0.06%
14,508
– –
RUBY
54
DELISTED
Rubius Therapeutics, Inc
RUBY
$173K 0.06%
986,878
– –
QS icon
55
QuantumScape Corp
QS
$3.22B
$164K 0.06%
28,951
– –
IPSC icon
56
Century Therapeutics
IPSC
$395M
$149K 0.05%
29,018
– –
RLYB icon
57
Rallybio
RLYB
$85.3M
$144K 0.05%
+2,735
New +$161K
DASH icon
58
DoorDash
DASH
$86.1B
$122K 0.04%
2,505
– –
PMVP icon
59
PMV Pharmaceuticals
PMVP
$60.3M
$100K 0.03%
11,533
– –
ASTR
60
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$81K 0.03%
12,444
– –
LOV
61
DELISTED
Spark Networks SE American Depositary Shares
LOV
$67.7K 0.02%
104,228
– –
GRNA
62
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$57.6K 0.02%
48,835
– –
OPEN icon
63
Opendoor
OPEN
$3.69B
$54.2K 0.02%
48,264
– –
ALGS icon
64
Aligos Therapeutics
ALGS
$26.7M
$17.9K 0.01%
751
– –
NXTC icon
65
NextCure
NXTC
$20.5M
$14.2K ﹤0.01%
837
– –
FLYW icon
66
Flywire
FLYW
$2.01B
– –
-17,172
Closed -$394K
GTLB icon
67
GitLab
GTLB
$5.7B
– –
-6,183
Closed -$317K
PLRX icon
68
Pliant Therapeutics
PLRX
$65.6M
– –
-64,826
Closed -$1.35M
RVMD icon
69
Revolution Medicines
RVMD
$40.9B
– –
-44,045
Closed -$869K
OYST
70
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-12,560
Closed -$71K
STRY
71
DELISTED
Starry Group Holdings, Inc.
STRY
– –
-666,667
Closed -$993K
1 2
3

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Harbourvest Partners held 71 positions worth $299M, down 2.4% from $306M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Harbourvest Partners's Q4 2022 filing shows 4 new, 2 increased, 1 reduced and 6 closed positions. Its largest new stake was Procore: 18,414 shares worth $869K. The largest sale was ZoomInfo Technologies, an estimated $8.07M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 61% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harbourvest Partners's largest Q4 2022 buy was Procore: 18,414 shares worth $869K.
  • Harbourvest Partners added most to Axcella Health Inc. Common Stock in Q4 2022, an estimated $1.9M increase.
  • Harbourvest Partners's biggest Q4 2022 reduction was ZoomInfo Technologies, cutting an estimated $8.07M.
  • Harbourvest Partners fully exited Pliant Therapeutics in Q4 2022, selling an estimated $1.35M.
  • Harbourvest Partners's ten largest holdings make up 80% of its $299M portfolio in Q4 2022.
  • Harbourvest Partners opened 4 new positions and closed 6 in Q4 2022.
  • Harbourvest Partners's portfolio value fell 2.4% quarter-over-quarter to $299M.

Based on Harbourvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.